Oxford Biomedica
Pioneering gene and cell therapy with innovative viral vector solutions for pharmaceutical and biotech companies. Learn more
Launch date
Employees
Market cap
AUD731m
Enterprise valuation
AUD746m (Public information from Sep 2024)
Share price
£3.51795 OXB.L
Company register number 03252665
Oxford England (HQ)
Authorizing premium user...